Table 4.

The current IDSA recommendations for serology and molecular testing.

Test Type	Recommending for	Comments
Serological	the evaluation of patients with a high clinical suspicion for COVID-19 and with negative molecular testing at at least two weeks since symptom onset	The certainty of available evidence supporting the use of serology for either diagnosis or epidemiology was, however, graded as very low to moderate. [211]
	he assessment of multisystem inflammatory syndrome in children
	the serosurveillance studies
Molecular	all symptomatic individuals suspected of having COVID-19	prioritization of testing will depend on institutional-specific resources and the needs of different patient populations. [211]
	asymptomatic individuals with known or suspected contact with a COVID-19 case
	asymptomatic individuals without known exposure is suggested when the results will impact isolation/quarantine/personal protective equipment (PPE) usage decisions, dictate eligibility for surgery, or inform solid organ or hematopoietic stem cell transplantation timing